Reconsidering the interpretation of dermoscopic criteria for acral lentiginous melanoma: dermoscopic features show promise, but real-world implementation faces unresolved barriers—a comment on Okwara et al. Authors: Shiqiong Zhou, Qinghua Ke Published: 2026 We read with great interest the recent meta-analysis by Okwara et al., titled “Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma: A Systematic Review and Meta-analysis,” published in JAMA Dermatology (Okwara et al. 2026). As clinicians involved in skin cancer diagnosis and melanoma surveillance, we commend the authors for providing the most comprehensive synthesis to date, reaffirming the parallel ridge pattern (79.6% sensitivity, 99.4% specificity) as the cornerstone of acral lentiginous melanoma (ALM) diagnosis and newly establishing the multicomponent pattern as a highly specific malignant feature. Their findings offer immediately actionable benchmarks for practice. However, we wish to raise three clinical and methodological considerations that may affect the generalizability and implementation of these promising results in real-world settings. First, approximately 20% of ALMs in this analysis did not exhibit the parallel ridge pattern, and the fibrillar pattern—traditionally considered benign—showed no statistically significant difference between nevi and melanoma (19.0% vs. 14.9%; pooled difference, − 3.5%; P = 0.31). This “diagnostic gap” represents a critical clinical vulnerability. While the pooled estimates provide population-level reassurance, the individual patient presenting with an acral pigmented lesion demands a more nuanced approach. Recent evidence suggests that mechanical stress sites on the plantar surface may exhibit dermoscopic variability, with some ALMs presenting with atypical or even furrow-like patterns. Therefore, absence of the parallel ridge pattern cannot override clinical suspicion, particularly for lesions with a history of change, ulceration, or location at high-pressure anatomical sites. We suggest that future prospective studies systematically document lesion location and mechanical stress exposure, and evaluate whether these factors influence the predictive value of dermoscopic patterns. Second, the reported 99.4% specificity of the parallel ridge pattern deserves scrutiny. As Okwara et al. acknowledge, only 25% of benign lesions in the included studies had histopathologic confirmation; the remainder were diagnosed by dermoscopic follow-up or clinical judgment alone. This introduces verification bias and may overestimate specificity. In routine clinical practice, a lesion with a clear parallel ridge pattern but no histologic confirmation of benignity should still be viewed with suspicion. Conversely, the absence of this pattern does not rule out ALM. We therefore recommend that future diagnostic accuracy studies for ALM report histopathologic confirmation rates for benign lesions and, whenever feasible, incorporate verification-bias corrections (e.g., partial verification bias adjustment) to provide unbiased specificity estimates. Third, from a health equity perspective, the intersection of dermoscopic patterns with race, skin phototype, and tumor biology remains severely understudied. Only 26.8% of included studies reported Fitzpatrick skin type, and just three studies specifically analysed dermoscopic findings in darker skin (Fitzpatrick IV–VI). Emerging evidence suggests that benign acral melanosis in patients with skin of colour can exhibit the parallel ridge pattern, potentially mimicking melanoma (Rodriguez et al. 2025, Manci et al. 2022). These observations challenge the absolute specificity of the parallel ridge pattern and suggest that baseline pigmentation patterns in darker phototypes may alter its positive predictive value. To our knowledge, dedicated prospective studies stratifying dermoscopic pattern analysis by Fitzpatrick skin type and assessing the performance of the parallel ridge pattern across diverse populations are currently lacking. We would be interested in the authors’ view on whether a modified algorithm incorporating clinical history (e.g., lesion change, patient age, and anatomic location) could improve diagnostic accuracy in patients with skin of colour, where the parallel ridge pattern may be less specific. In summary, Okwara et al. have provided valuable evidence supporting the parallel ridge and multicomponent patterns as key dermoscopic features for ALM diagnosis. Nonetheless, careful attention to the diagnostic gap in pattern‑negative ALMs, verification bias in specificity estimates, and the underrepresentation of diverse skin phototypes will be essential before these findings can be applied equitably and safely in routine practice. We look forward to future studies addressing these real‑world barriers. Author contributions Ke QH: Investigation, Resources, Validation, Writing—original draft, Writing—review & editing, Data curation, Supervision, Formal analysis, Conceptualization.Zhou SQ: Writing—review & editing, Conceptualization, Writing—original draft, Formal analysis, Data curation. Funding None. Data availability No new data were generated or analyzed in support of this commentary. All data discussed are derived from previously published studies cited in the reference list, primarily Okwara CJ et al. (JAMA Dermatol., 2026). The corresponding author may be contacted for inquiries regarding the interpretation of cited data, but no original datasets are associated with this manuscript. Declarations Competing interests The authors declare no competing interests. Ethical statement As this article is a commentary on published meta-analysis data and does not involve original research with human participants, patient data, or animal subjects, no ethical approval was required. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No new data were generated or analyzed in support of this commentary. All data discussed are derived from previously published studies cited in the reference list, primarily Okwara CJ et al. (JAMA Dermatol., 2026). The corresponding author may be contacted for inquiries regarding the interpretation of cited data, but no original datasets are associated with this manuscript.